Key PointsReduced stake by 140,000 shares; estimated transaction value of $4.11 million based on quarterly average price

With a forward P/E ratio of 17.67, NVIDIA Corporation (NASDAQ:NVDA) is among the 10 Best Growth Stocks to Buy with Low P/E Ratios. On May 21, Raymond James raised its price target on NVIDIA Corporation (NASDAQ:NVDA) to $330 from $323 while maintaining a Strong Buy rating on the shares. The firm stated that Nvidia delivered stronger-than-expected first-quarter results alongside […]

Nvidia (NVDA) Delivers Another Beat As A New AI Trend Gains Momentum Yahoo Finance

Meta Platforms (NASDAQ:META) just reported one of the strangest quarters in mega-cap tech. Revenue grew 33.08% to $56.31 billion, advertising surged 33% year-over-year, and CEO Mark Zuckerberg told investors “We’re on track to deliver personal superintelligence to billions of people.” Yet shares are down 7.47% year-to-date and sit at $610.26. The question I want to ... Can Meta Stock Reach $1,500 by 2030?

印度尼西亚媒体5月31日消息，该国东部巴布亚省当天发生了一起第二次世界大战遗留炸弹爆炸事件，目前已造成5人死亡，另有3人下落不明。当地警方说，事发时间为当天下午，事发地是人口稠密区，爆炸对附近房屋造成严重破坏。由于担心现场可能还有未爆炸弹，对下落不明人员的搜救在夜间暂停。警方还说，爆炸由一枚二战时期遗留的炸弹引发，目前已封锁事故现场、疏散居民。搜救工作将于6月1日恢复。（新华社）

Up 28% in weeks, could Tesla stock go even higher? Yahoo Finance UK

The former Scottish first minister’s security in her own power and authority seems to have gone, writes Laura Kuenssberg.

A national school exam board in India said it has been monitoring and has contained vulnerabilities in its online grading portal for one of the country’s most important school-leaving exams that were first flagged by a teenage cybersecurity researcher. The Central Board of Secondary Education, run by the government and one of India’s main school exam boards, said in an X post that it has been “closely monitoring” weaknesses in the OnMark portal — an online grading website for teachers — after they were flagged publicly. The portal, which was first introduced this year, uploads scanned copies of physical answer book of students for teachers to grade digitally. The controversy stems from complaints by students that their physical answer sheets did not match the digital versions shared by the education board upon request for reevaluation. The incident has sparked outrage on social media platforms, forcing the CBSE and the country’s Education Minister Dharmendra Pradhan to address the concerns. In India, millions of students every year sit for the crucial exam that is a gateway for further higher studies. This year around 1.8 million took the exam across the country, according to a statement by the CBSE. The board announced the result of the exams on May 13. “The identified vulnerabilities have been contained, and other exploitable weaknesses are being ruled out,” the board said in the post. Cybersecurity experts from government agencies and top engineering colleges had been deployed over the past several days to strengthen the systems, including moving them to “a more secure set up,” it said. It’s the latest episode to beset India’s education industry that was earlier this month rocked by the annulment of a national exam for medical students after a probe. It has also raised questions about the security of digital exam-marking infrastructure in one of the world’s largest school systems and heightened pressure on Prime Minister Narendra Modi ’s administration to address...

Purgatory of the Markets: Navigating NDX Volatility Amidst NVDA Earnings Nasdaq

Elon Musk-Led Tesla's Former AI Trainers Do Not Trust Its Self-Driving Tech, Safety Data: Repor Benzinga

Sundry Photography/iStock Editorial via Getty Images Johnson & Johnson ( JNJ ) reported new clinical trial results showing that its experimental subcutaneous formulation of amivantamab produced durable responses in patients with advanced head and neck cancer whose disease had progressed after immunotherapy and chemotherapy. The data, presented at the American Society of Clinical Oncology's annual meeting and published simultaneously in the Journal of Clinical Oncology , come as the company seeks U.S. regulatory approval for the treatment in recurrent or metastatic head and neck squamous cell carcinoma. In the Phase 1b/2 OrigAMI-4 study, the treatment achieved a confirmed overall response rate of 42% in previously treated patients. More than one-third of patients who responded experienced complete responses, meaning no detectable evidence of cancer remained. The median duration of response had not yet been reached after a median follow-up of nearly 12 months. The results are important for investors because they could support a label expansion for Johnson & Johnson's amivantamab franchise beyond its current uses in lung cancer. Head and neck cancer remains an area with limited treatment options after standard therapies fail, and a new approval could broaden the drug's commercial opportunity while reinforcing the company's strategy of expanding the medicine into multiple tumor types. Head and neck squamous cell carcinoma is an aggressive cancer that can affect the mouth, throat and voice box. Many patients eventually develop recurrent or metastatic disease despite earlier treatment, and survival rates remain low once the cancer spreads. According to Johnson & Johnson, current treatments for patients who have already received immunotherapy and chemotherapy typically produce response rates below 25%, with complete responses being uncommon. The therapy, marketed as Rybrevant Faspro, combines amivantamab with hyaluronidase and is administered as a subcutaneous injection ra...

Key PointsNvidia's revenue growth is accelerating as hyperscalers continue to scale up their data center infrastructure.

Nvidia Shares Dropped After Stellar Earnings. Is This a Sign of What's Coming for Artificial Intelligence (AI) Stocks? Yahoo Finance

Warning: A key part of the options market you may be relying on is no longer working.

Paying off your home seems like a quick and predictable return, but there are several factors to consider before you give up on stock market gains.

Parabolic Semiconductor Rally: What Breaks The Trade? Authored by Lance Roberts via RealInvestmentAdvice.com, AI Validation Fuels A Ninth Weekly Advance The headline tape made fresh history. The S&P 500 closed Friday at 7,580.06 , finishing up 1.43% on the week and posting its ninth consecutive weekly gain. That’s the longest weekly winning streak since 2024, and only the 5th time since 1965 that has occurred. While markets previously saw weakness following such streaks, the 24- and 52-week outcomes were primarily positive, except in 1989. However, the Russell 2000 actually fell 0.59% to 2,919, a reminder that the small-cap participation everyone hoped for in March still hasn’t shown up despite the megacap rip. Underneath the headline, the dispersion that’s defined this rally has only widened. Technology and financials carried Friday’s tape while energy lagged on falling crude. Two macro stories collided midweek, and the market chose to celebrate one and shrug at the other. First, the April PCE inflation print landed Thursday morning with the highest headline reading in nearly three years at 3.8% year-over-year, with core PCE at 3.3%. However, the monthly core reading came in at 0.2%, below the 0.3% consensus, and that softer monthly tone gave the Fed-cut camp something to work with. Second, Axios reported Thursday that the US and Iran had reached a tentative 60-day Memorandum of Understanding to extend the ceasefire framework. Oil promptly slid to a six-week low near $89 WTI, the VIX collapsed to its lowest reading since January, ending the week at 15.32, and the rally accelerated. The combination of a softer core PCE and a reduced geopolitical premium handed equity bulls everything they wanted in two sessions. The dominant micro story came after the bell on Thursday. Dell Technologies reported fiscal Q1 results that were, by any measure, extraordinary, with revenue hitting a record $43.8 billion , up 88% year-over-year, $24.4 billion in AI orders booked, and $16.1...

格隆汇5月31日丨白宫国家经济委员会主任哈塞特周日表示，媒体对经济新闻的报道方式往往会让人们过度关注到某一特定时刻所存在的最严重问题。哈塞特在出席美国广播公司《本周》节目时说：“我在白宫注意到的一点是，只要是某项消费价格数据看起来有点令人失望，我们就只谈论这一项。”他就汽油价格及其对通胀影响的问题作出上述表态。哈塞特表示，每个人都应着眼全局，而不仅仅是能源价格或经济中某个暂时遇到困难的领域。“你应该做的是从容看待这些涨跌，关注实际工资的变化情况。”他说，“如果你仔细观察，就会发现由于就业人数增加、股市上涨，企业利润丰厚，这正在转化为薪资水平的提高。”

The reaction to this morning's exclusive interview following Peter Murrell’s guilty plea

Key PointsThe cost of housing in California is inordinately expensive.

Taiwan condemns China after New York Times reporter expelled after presidential interview Reuters

Randolph Altschuler, Chief Executive Officer of Xometry (NASDAQ:XMTR) , reported the indirect sale of 50,000 shares for a transaction value of approximately $4.4 million on May 21, 2026, as disclosed in this SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($87.85); post-transaction value based on May 21, 2026, market close ($87.85). * 1-year performance calculated as of May 29, 2026. Continue reading

Peloton (NASDAQ:PTON) , a leader in connected fitness and digital subscriptions, reported a sale by its Chief Commercial Officer amid ongoing market challenges. Sanders Dion C., Chief Commercial Officer of Peloton, reported the sale of 112,523 directly held shares of common stock for a total transaction value of approximately $584,000, according to the SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($5.19); post-transaction value was $0.00, as all shares were sold. Continue reading

BorgWarner (NYSE: BWA) is a name investors associate with turbochargers and drivetrains, but now it's thrown its hat into the hyperscaler ring. In February, the company signed a master supply agreement to provide modular turbine generators to help power data centers. The deal with TurboCell, a subsidiary of infrastructure developer Endeavor, marks an important entry into the industrial power market. Management expects production to begin in 2027, with sales exceeding $300 million in the first year and the potential to grow in the "mid-teens" over the coming decade. Image source: Getty Images. Continue reading

Carl Dambkowski, Director of Oruka Therapeutics (NASDAQ:ORKA) , reported the sale of 105,000 shares of Common Stock for a total of approximately $6.19 million on May 21, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($58.97); post-transaction value based on May 21, 2026, market close ($58.69). * 1-year performance calculated using May 28, 2026, as the reference date. Continue reading

格隆汇5月31日｜刚果(金)政府当地时间5月30日通报本轮埃博拉疫情防控最新进展，目前该国累计确诊病例超260例，疫情波及伊图里省、北基伍省及南基伍省多地。